HIGHLIGHTS
- who: Takashi Imai and colleagues from the Department of Infectious Diseases and Host Defense, Graduate School of Medicine, Gunma University have published the research: Live Vaccination with Blood-Stage Plasmodium yoelii 17XNL Prevents the Development of Experimental Cerebral Malaria, in the Journal: Vaccines 2022, 10, 762. of 11/05/2022
- what: The authors aim to develop a malaria vaccine with cross-strain (-species) protection. The authors attempted to develop a new method for preventing ECM without immune cell depletion. The authors demonstrated that live vaccination with PyNL provided sterile and long-term immunity against infection . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.